Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a quick bedside lactate test to improve prioritization for patients triaged as yellow by the Manchester system

Official title: Impact of Point-of-care Lactate Testing as Triage Supplement on Patient Management Using Manchester Triage System

Run by University Medical Centre Maribor · NCT07123857 · Data updated 2026-11-12

This trial will test whether adding a rapid bedside blood lactate test helps emergency staff better prioritize care for patients assigned the yellow Manchester triage category.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity Medical Centre Maribor
Academic / other
Locations1 site (Maribor)
StatusRecruiting
StartedJuly 10, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 14, 2025
Trial IDNCT07123857 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are consenting patients who arrive at the emergency department and are assigned the yellow Manchester triage category, excluding pregnant patients, trauma cases, those with seizures, or patients who received prehospital adrenergic therapy.

Probably not a fit

Patients in other triage categories, pregnant patients, trauma patients, those with epileptic seizures, or those who received prehospital adrenergic therapy would not be eligible and are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized trial that enrolls adult patients placed in the yellow category by the Manchester Triage System at the University Medical Center Maribor. Enrolled patients will be randomized to standard triage versus triage supplemented with a point-of-care lactate measurement and possible re-triage based on the result. The trial excludes pregnant patients, trauma cases, patients with epileptic seizures, and those who received adrenergic therapy in the prehospital setting. Outcomes focus on changes in patient management and identification of higher-risk patients within the yellow category.

Why it matters

Potential benefit: If successful, the approach could identify higher-risk patients earlier within the yellow category and reduce under-triage and unsafe delays.

How similar studies have gone: Observational and ED studies have shown that elevated lactate is linked to higher mortality and can aid risk stratification, but randomized evidence specifically using point-of-care lactate as a routine triage supplement is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* signed consent, yellow MTS triage category

Exclusion Criteria:

* pregnant women, trauma patients, epileptic seizures, adrenergic therapy in prehospital unit

Where it's running

  • University Medical Center Maribor
    Maribor, Slovenia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.